These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

944 related articles for article (PubMed ID: 27545621)

  • 1. ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain.
    Conicella AE; Zerze GH; Mittal J; Fawzi NL
    Structure; 2016 Sep; 24(9):1537-49. PubMed ID: 27545621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TDP-43 α-helical structure tunes liquid-liquid phase separation and function.
    Conicella AE; Dignon GL; Zerze GH; Schmidt HB; D'Ordine AM; Kim YC; Rohatgi R; Ayala YM; Mittal J; Fawzi NL
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5883-5894. PubMed ID: 32132204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulins modulate liquid-liquid phase separation and aggregation of the prion-like C-terminal domain of the neurodegeneration-associated protein TDP-43.
    Bhopatkar AA; Uversky VN; Rangachari V
    J Biol Chem; 2020 Feb; 295(8):2506-2519. PubMed ID: 31911437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAR DNA-binding protein 43 (TDP-43) liquid-liquid phase separation is mediated by just a few aromatic residues.
    Li HR; Chiang WC; Chou PC; Wang WJ; Huang JR
    J Biol Chem; 2018 Apr; 293(16):6090-6098. PubMed ID: 29511089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zn
    Preethi S; Bharathi V; Patel BK
    Int J Biol Macromol; 2021 Apr; 176():186-200. PubMed ID: 33577819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALS-causing cleavages of TDP-43 abolish its RRM2 structure and unlock CTD for enhanced aggregation and toxicity.
    Wei Y; Lim L; Wang L; Song J
    Biochem Biophys Res Commun; 2017 Apr; 485(4):826-831. PubMed ID: 28257838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of ALS-linked M337V mutation on the conformational ensembles of TDP-43
    Zeng J; Tang Y; Dong X; Li F; Wei G
    Proteins; 2024 Sep; 92(9):1059-1069. PubMed ID: 36841957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residue-by-Residue View of In Vitro FUS Granules that Bind the C-Terminal Domain of RNA Polymerase II.
    Burke KA; Janke AM; Rhine CL; Fawzi NL
    Mol Cell; 2015 Oct; 60(2):231-41. PubMed ID: 26455390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing.
    Wang A; Conicella AE; Schmidt HB; Martin EW; Rhoads SN; Reeb AN; Nourse A; Ramirez Montero D; Ryan VH; Rohatgi R; Shewmaker F; Naik MT; Mittag T; Ayala YM; Fawzi NL
    EMBO J; 2018 Mar; 37(5):. PubMed ID: 29438978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The physical forces mediating self-association and phase-separation in the C-terminal domain of TDP-43.
    Li HR; Chen TC; Hsiao CL; Shi L; Chou CY; Huang JR
    Biochim Biophys Acta Proteins Proteom; 2018 Feb; 1866(2):214-223. PubMed ID: 28988034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons.
    Gopal PP; Nirschl JJ; Klinman E; Holzbaur EL
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2466-E2475. PubMed ID: 28265061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALS-Causing Mutations Significantly Perturb the Self-Assembly and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43.
    Lim L; Wei Y; Lu Y; Song J
    PLoS Biol; 2016 Jan; 14(1):e1002338. PubMed ID: 26735904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase to Phase with TDP-43.
    Sun Y; Chakrabartty A
    Biochemistry; 2017 Feb; 56(6):809-823. PubMed ID: 28112502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis.
    Pesiridis GS; Lee VM; Trojanowski JQ
    Hum Mol Genet; 2009 Oct; 18(R2):R156-62. PubMed ID: 19808791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity.
    Johnson BS; Snead D; Lee JJ; McCaffery JM; Shorter J; Gitler AD
    J Biol Chem; 2009 Jul; 284(30):20329-39. PubMed ID: 19465477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.
    French RL; Grese ZR; Aligireddy H; Dhavale DD; Reeb AN; Kedia N; Kotzbauer PT; Bieschke J; Ayala YM
    J Biol Chem; 2019 Apr; 294(17):6696-6709. PubMed ID: 30824544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43).
    Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M
    J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational insights into mechanism of AIM4-mediated inhibition of aggregation of TDP-43 protein implicated in ALS and evidence for in vitro inhibition of liquid-liquid phase separation (LLPS) of TDP-43
    Girdhar A; Bharathi V; Tiwari VR; Abhishek S; Deeksha W; Mahawar US; Raju G; Singh SK; Prabusankar G; Rajakumara E; Patel BK
    Int J Biol Macromol; 2020 Mar; 147():117-130. PubMed ID: 31917988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43 NTD can be induced while CTD is significantly enhanced by ssDNA to undergo liquid-liquid phase separation.
    Wang L; Kang J; Lim L; Wei Y; Song J
    Biochem Biophys Res Commun; 2018 May; 499(2):189-195. PubMed ID: 29555476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation.
    Tanaka Y; Nonaka T; Suzuki G; Kametani F; Hasegawa M
    Hum Mol Genet; 2016 Apr; 25(7):1420-33. PubMed ID: 26908597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.